Integrating Cryptococcal Antigen Screening and Pre-Emptive Treatment into Routine HIV Care
- 15 April 2012
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 59 (5), e85-e91
- https://doi.org/10.1097/qai.0b013e31824c837e
Abstract
Cryptococcal meningitis is a leading cause of death in AIDS patients in sub-Saharan Africa. Cryptococcal antigen (CRAG) can be detected weeks before onset of symptoms, and those who are asymptomatic but CRAG positive have a high risk of subsequent cryptococcal meningitis and mortality. A new CRAG point of care immunochromatographic test is available that is remarkably easy to administer without laboratory infrastructure or expertise and has excellent sensitivity and specificity. We review the benefits of targeted CRAG screening, developments in CRAG diagnostics, and evidence regarding treatment options that can be implemented into routine HIV care in areas of high cryptococcal burden. Based on published CRAG+ prevalence rates of 2%–12%, the cost to save one life is between $20 to $140 in sub-Saharan Africa. We provide recommendations for implementation, pre-emptive treatment, and identify the gaps in our current knowledge.Keywords
This publication has 27 references indexed in Scilit:
- Evaluation of a Novel Point-of-Care Cryptococcal Antigen Test on Serum, Plasma, and Urine From Patients With HIV-Associated Cryptococcal MeningitisClinical Infectious Diseases, 2011
- Prevalence, Determinants of Positivity, and Clinical Utility of Cryptococcal Antigenemia in Cambodian HIV-Infected PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2007
- Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural UgandaTropical Medicine & International Health, 2007
- Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South AfricaAIDS, 2007
- Determinants of Mortality and Nondeath Losses from an Antiretroviral Treatment Service in South Africa: Implications for Program EvaluationClinical Infectious Diseases, 2006
- Systematic Screening of Cryptococcal Antigenemia in HIV-Positive Adults in UgandaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2003
- Cryptococcal infection in a cohort of HIV-1-infected Ugandan adultsAIDS, 2002
- Bacterial Meningitis in Malawian Adults: Pneumococcal Disease is Common, Severe, and SeasonalClinical Infectious Diseases, 2000
- Serum Cryptococcal Antigen in Patients with AIDSClinical Infectious Diseases, 1996
- The value of cryptococcal serum antigen screening among HIV-positive/AIDS patients in Kinshasa, ZaireAIDS, 1989